Related Experiment Videos
Human restriction fragment length polymorphisms and cancer risk assessment
Journal of Cellular Biochemistry
|January 1, 1986
Summary
Rare alleles of the human Ha-ras locus, identified by variable tandem repeat (VTR) analysis, are found in cancer patients. This Ha-ras restriction fragment length polymorphism may aid in cancer risk assessment.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- The human Ha-ras locus exhibits polymorphic restriction fragments due to variable tandem repeats (VTR).
- These polymorphisms can be classified into three groups based on allelic frequencies.
Purpose of the Study:
- To investigate the association of rare Ha-ras alleles with cancer.
- To determine the utility of Ha-ras restriction fragment length polymorphism in cancer risk assessment.
Main Methods:
- Analysis of polymorphic restriction fragments of the human Ha-ras locus.
- Variable tandem repeat (VTR) analysis to classify alleles based on frequency.
- Comparison of allele frequencies in cancer patients versus the general population.
- Assessment of an independent tandem repeat locus (VTR4.1) for comparison.
Main Results:
- Rare Ha-ras alleles (frequency <0.5%) were detected exclusively in white blood cell and tumor DNA from cancer patients.
- This finding was independent of the patients' ethnic origin.
- No significant association of rare alleles was observed at the VTR4.1 locus.
Conclusions:
- The Ha-ras restriction fragment length polymorphism, specifically rare alleles, shows a strong association with cancer.
- This polymorphism holds potential as a biomarker for cancer risk assessment.